Compare SS&C Technologies Holdings Inc. Common Stock (SSNC) vs Teladoc Health Inc (TDOC) Price & Performance

SSNC trades at $81.52, up 0.65% on the day, with a neutral technical signal. The company has consistently beaten earnings estimates in recent quarters (Q4 2025, Q1 2026, Q2 2026) and shows solid fundamentals, including a 13.16% net income margin and 12.73% ROE. Recent news highlights new client wins and AI-driven product enhancements, reinforcing its market position.

The outlook is positive, supported by strong analyst consensus (70.83% Buy rating) and a $91.50 price target, implying ~12% upside. Key risks include execution of growth initiatives and competitive pressures in the financial technology sector. The stock presents a compelling opportunity for investors seeking a fundamentally sound company with recurring revenue streams.

Teladoc Health trades at $6.00, showing modest daily gains but remains near multi-year lows with bearish technical signals. The company maintains strong revenue around $2.5B annually but continues posting net losses, though improving from historical levels. Recent management changes and ongoing BetterHelp challenges create uncertainty, while the Integrated Care segment shows promise. Valuation metrics appear attractive with P/S of 0.43 and P/B of 0.83, suggesting potential undervaluation if profitability improves.

The stock presents a high-risk opportunity with significant upside potential if management can stabilize operations and achieve profitability. Analyst consensus targets $8.83 (47% upside) with no sell ratings, but execution risks remain elevated. Key catalysts include successful CFO transition, BetterHelp stabilization, and Integrated Care margin expansion. Investors should weigh the attractive valuation against persistent losses and competitive pressures in telehealth.